NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

Expert Review of Anticancer Therapy
Alexander T FalkM Ilie

Abstract

The advent of genomic based precision medicine led to the implementation of biomarker testing in metastatic non-small cell lung cancer (NSCLC) patients. Next generation sequencing (NGS) has been recently implemented to routine diagnostic requirements in lung oncology. Areas covered: Two cases of patients with metastatic NSCLC for whom NGS analysis performed on both tumor and liquid biopsy has not improved the clinical course of their disease are reported. These cases illustrate the difficulty of the so-called 'personalized or precision' medicine in clinical routine practice for metastatic NSCLC. Expert commentary: Discovery and detection of critical cancer-gene alterations better indicates targeted therapies that must be administered to improve the care of NSCLC patients in the personalized medicine era. There has been much interest in the literature and the scientific community for NGS tailored therapies approach for patients. However, there may be a gap between this theoretical stratified medicine and clinical practice. The advantages and drawbacks of NGS on tumor tissue and cell-free DNA for metastatic NSCLC are discussed.

References

Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Nov 24, 2012·Cancer Letters·Jiekun XuanLeming Shi
Apr 9, 2013·The Journal of Molecular Diagnostics : JMD·Neal I Lindeman College of American Pathologists International Association for the Study of Lung Cancer and Association for Molecular Pathol
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Feb 11, 2014·The Lancet Oncology·Charles Swanton
Jul 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sébastien CouraudPierre-Jean Souquet
Oct 31, 2014·Archives of Pathology & Laboratory Medicine·Birgitte B SimenZi-Xuan Wang
Mar 18, 2015·American Journal of Clinical Pathology·John W J HinrichsRoel A de Weger
May 13, 2015·Nature Reviews. Clinical Oncology·Anish ThomasGiuseppe Giaccone
Oct 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cloud P PaweletzGeoffrey R Oxnard
Jan 14, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cécile JoveletLudovic Lacroix
Nov 9, 2016·Translational Lung Cancer Research·Umberto MalapelleGiancarlo Troncone
Dec 3, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Arnaud PagèsJulia Bonastre
Dec 4, 2016·Hematology/oncology Clinics of North America·Siddhartha DevarakondaRamaswamy Govindan
Dec 17, 2016·OncoTargets and Therapy·Simona SerratìRosamaria Pinto
Apr 11, 2017·Respiratory Medicine Case Reports·Takuma ImakitaTadashi Mio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.